Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Fortis Healthcare

₹440.3 -11.4 | 2.5%

Market Cap ₹33241 Cr.

Stock P/E 60.1

P/B 4.3

Current Price ₹440.3

Book Value ₹ 102.5

Face Value 10

52W High ₹470.1

Dividend Yield 0.23%

52W Low ₹ 265.1

Fortis Healthcare Research see more...

Overview Inc. Year: 1996Industry: Hospital & Healthcare Services

Fortis Healthcare Ltd is an India-based incorporated healthcare shipping carrier provider. The Company is frequently engaged in the enterprise of healthcare services. It operates via 2 segments: Healthcare and Diagnostics. Its specialities comprises cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, pulmonology, urology, neurosurgery, radiology, orthopaedics and ophthalmology, amongst others. It manages and operates a network of multi-area of expertise hospitals and diagnostics centres. The healthcare verticals of the Company mainly includes hospitals, diagnostics and day care speciality centres. It has about 36 healthcare facilities, including tasks underneath development, 4000 operational beds and over 400 diagnostics centers. It operates in India, Sri Lanka, and United Arab Emirates.Its subsidiaries consist of Fortis Healthstaff Ltd, Escorts Heart Institute and Research Centre Ltd, Fortis Asia Healthcare Pte. Ltd, among others.

Read More..

Fortis Healthcare Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Fortis Healthcare Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 1463 1467 1378 1488 1607 1560 1643 1657 1770 1680
Other Income 8 7 6 21 16 12 14 8 14 7
Total Income 1471 1473 1384 1509 1623 1572 1656 1666 1783 1686
Total Expenditure 1178 1180 1157 1237 1304 1283 1372 1385 1440 1396
Operating Profit 292 294 227 272 318 288 285 281 344 291
Interest 40 38 30 31 33 33 32 31 32 33
Depreciation 75 76 77 74 77 83 82 79 84 87
Exceptional Income / Expenses 0 8 0 0 52 11 11 1 4 8
Profit Before Tax 178 188 120 166 260 183 182 171 231 179
Provision for Tax 51 51 39 42 50 44 45 47 49 49
Profit After Tax 126 137 81 124 211 140 137 125 183 130
Adjustments -20 -20 -13 -2 -6 -10 -4 -13 -9 5
Profit After Adjustments 107 117 68 122 204 130 133 112 174 135
Adjusted Earnings Per Share 1.4 1.5 0.9 1.6 2.7 1.7 1.8 1.5 2.3 1.8

Fortis Healthcare Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 3042 3492 3966 4199 4574 4561 4469 4632 4030 5718 6298 6750
Other Income 151 167 96 153 166 140 92 53 47 27 62 43
Total Income 3193 3659 4062 4352 4740 4701 4562 4685 4077 5745 6359 6791
Total Expenditure 2820 3440 3835 3995 4221 4288 4244 4023 3626 4649 5196 5593
Operating Profit 374 219 226 358 519 413 318 662 451 1096 1163 1201
Interest 461 250 152 133 229 258 337 205 166 147 129 128
Depreciation 229 183 235 225 222 239 233 292 291 301 316 332
Exceptional Income / Expenses 996 -5 0 -40 -2 -881 -222 62 1 315 74 24
Profit Before Tax 679 -219 -160 32 552 -912 -110 239 43 988 814 763
Provision for Tax 175 11 5 -8 72 23 114 148 99 198 181 190
Profit After Tax 505 -229 -164 40 479 -934 -224 91 -56 790 633 575
Adjustments -5 352 20 -21 -58 -75 -75 -34 -54 -235 -44 -21
Profit After Adjustments 500 123 -144 18 422 -1009 -299 58 -110 555 589 554
Adjusted Earnings Per Share 12.3 2.6 -3.1 0.4 8.1 -19.5 -4 0.8 -1.5 7.4 7.8 7.4

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 10% 11% 7% 8%
Operating Profit CAGR 6% 21% 23% 12%
PAT CAGR -20% 91% 0% 2%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 64% 23% 27% 16%
ROE Average 9% 7% 4% 1%
ROCE Average 13% 10% 8% 5%

Fortis Healthcare Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 4381 4952 4718 4461 5143 4062 6601 6661 6120 6178 7242
Minority's Interest 1021 139 153 392 1167 1255 512 544 598 830 858
Borrowings 4817 1659 1004 867 1279 948 637 954 968 779 572
Other Non-Current Liabilities 186 129 107 -163 -32 -73 145 216 1866 2459 1991
Total Current Liabilities 3108 972 1602 1450 1881 2133 3591 2578 1232 1268 1314
Total Liabilities 13514 7851 7585 7007 9484 8327 11486 10955 10784 11516 12089
Fixed Assets 9274 4147 4218 3642 5419 4992 8477 8802 8799 9416 9426
Other Non-Current Assets 1684 1664 1731 1951 2290 2053 1343 1212 949 967 1257
Total Current Assets 2556 2040 1636 1414 1728 1278 1666 938 1033 1130 1150
Total Assets 13514 7851 7585 7007 9484 8327 11486 10955 10784 11516 12089

Fortis Healthcare Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 405 485 249 179 123 348 -165 634 7 219 67
Cash Flow from Operating Activities 1644 479 24 195 966 493 -179 172 485 865 822
Cash Flow from Investing Activities -1003 2669 213 113 -1002 -335 -3323 60 -135 -514 -374
Cash Flow from Financing Activities -74 -3217 -304 -354 259 -672 4257 -862 -143 -517 -471
Net Cash Inflow / Outflow 567 -69 -67 -47 224 -515 755 -630 207 -166 -23
Closing Cash & Cash Equivalent 485 249 183 142 348 -165 634 7 219 67 45

Fortis Healthcare Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 12.34 2.65 -3.11 0.4 8.14 -19.46 -3.96 0.77 -1.45 7.35 7.8
CEPS(Rs) 18.1 -1 1.52 5.72 13.55 -13.41 0.12 5.08 3.11 14.45 12.57
DPS(Rs) 0 0.01 0 0 0 0 0 0 0 0 1
Book NAV/Share(Rs) 91.47 92.53 87.46 89.67 99.01 77.77 87.12 88.18 81.04 81.81 95.91
Core EBITDA Margin(%) 7.31 1.49 3.29 4.86 7.72 5.99 5.04 13.16 10.04 18.7 17.49
EBIT Margin(%) 37.49 0.9 -0.2 3.92 17.08 -14.34 5.07 9.59 5.19 19.84 14.97
Pre Tax Margin(%) 22.33 -6.26 -4.02 0.75 12.06 -19.99 -2.46 5.17 1.07 17.28 12.92
PAT Margin (%) 16.58 -6.57 -4.14 0.95 10.48 -20.49 -5.01 1.98 -1.39 13.82 10.05
Cash Profit Margin (%) 24.1 -1.33 1.78 6.31 15.34 -15.25 0.21 8.27 5.82 19.08 15.06
ROA(%) 3.9 -2.15 -2.13 0.54 5.81 -10.49 -2.26 0.82 -0.52 7.08 5.36
ROE(%) 15.28 -5.74 -3.94 0.97 10.33 -20.4 -4.22 1.38 -0.88 12.85 9.44
ROCE(%) 11.06 0.36 -0.12 2.64 11.72 -9.77 3.11 5.36 2.72 15.61 12.5
Receivable days 72.51 57.67 39.12 37.09 36.59 37.74 41.35 39.44 41.5 30.96 31.7
Inventory Days 10.34 8.07 5.8 5.39 4.85 5.13 5.03 5.31 7.02 6.37 7.12
Payable days 384.15 282.05 197.33 211.28 210.4 246.88 298.12 255.83 214.28 162.58 172.53
PER(x) 8.1 36.93 0 441.05 22.11 0 0 164.26 0 39.49 33.33
Price/Book(x) 1.09 1.06 1.88 1.96 1.82 1.59 1.56 1.43 2.46 3.55 2.71
Dividend Yield(%) 0 0.01 0 0 0 0 0 0 0 0 0.38
EV/Net Sales(x) 3.51 1.95 2.49 2.33 2.4 1.79 2.54 2.29 3.94 3.93 3.17
EV/Core EBITDA(x) 28.6 31.06 43.63 27.33 21.19 19.72 35.79 16.01 35.21 20.5 17.17
Net Sales Growth(%) 16.22 14.78 13.57 5.88 8.93 -0.28 -2.01 3.65 -13 41.87 10.14
EBIT Growth(%) 231.24 -97.24 -124.62 2222.8 374.13 -183.72 134.67 96.01 -52.93 442.43 -16.91
PAT Growth(%) 792.94 -145.45 28.45 124.21 1106.81 -294.96 76.06 140.9 -161.39 1506.38 -19.87
EPS Growth(%) 592.16 -78.54 -217.26 112.81 1947.39 -338.91 79.65 119.38 -289.46 605.74 6.05
Debt/Equity(x) 1.48 0.38 0.38 0.34 0.43 0.49 0.3 0.2 0.21 0.16 0.1
Current Ratio(x) 0.82 2.1 1.02 0.97 0.92 0.6 0.46 0.36 0.84 0.89 0.88
Quick Ratio(x) 0.79 2.11 0.99 0.93 0.89 0.57 0.45 0.33 0.78 0.79 0.78
Interest Cover(x) 2.47 0.13 -0.05 1.24 3.4 -2.54 0.67 2.17 1.26 7.73 7.3
Total Debt/Mcap(x) 1.6 0.42 0.23 0.19 0.24 0.31 0.19 0.14 0.08 0.04 0.04

Fortis Healthcare Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 31.17 31.17 31.17 31.17 31.17 31.17 31.17 31.17 31.17 31.17
FII 30.08 29.82 29.66 30.59 31.01 31.22 30.03 30.03 23.71 23.24
DII 15.67 16.9 17.6 20.03 20.38 20.69 22.16 22.16 29.41 31.15
Public 23.08 22.12 21.57 18.22 17.45 16.92 16.64 16.64 15.71 14.45
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 31.17%.
  • Company has a low return on equity of 7% over the last 3 years.
  • Debtor days have increased from 162.58 to 172.53days.
  • Stock is trading at 4.3 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Fortis Healthcare News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....